Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 260 results.
User Information
Export Records
  1. 1.   NADPH oxidase 1 is highly expressed in human large and small bowel cancers
  2. Lu, Jiamo; Jiang, Guojian; Wu, Yongzhong; Antony, Smitha; Meitzler, Jennifer L; Juhasz, Agnes; Liu, Han; Roy, Krishnendu; Makhlouf, Hala; Chuaqui, Rodrigo; Butcher,Donna; Konaté, Mariam M; Doroshow, James H
  3. PloS one. 2020, May 19; 15(5): e0233208.
  1. 2.   Antineoplastic Agents. 548. Synthesis of lodo- and Diiodocombstatin Phosphate Prodrugs
  2. Pettit, G. R.; Rosenberg, H. J.; Dixon, R.; Knight, J. C.; Hamel, E.; Chapuis, J. C.; Pettit, R. K.; Hogan, F.; Sumner, B.; Ain, K. B.; Trickey-Platt, B.
  3. Journal of Natural Products. 2012, Mar; 75(3): 385-393.
  1. 3.   Characterization, Mapping, and Distribution of the Two XMRV Parental Proviruses
  2. Cingoz, O.; Paprotka, T.; Delviks-Frankenberry, K. A.; Wildt, S.; Hu, W. S.; Pathak, V. K.; Coffin, J. M.
  3. Journal of Virology. 2012, Jan; 86(1): 328-338.
  1. 4.   Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
  2. Tsai, Y. C.; Weissman, A. M.
  3. Febs Letters. 2011, Oct; 585(20): 3166-3173.
  1. 5.   Plasma and CNS pharmacokinetics of O(4)-benzylfolic acid (O(4)BF) and metabolite in a non-human primate model
  2. Chuk, M. K.; Cole, D. E.; McCully, C.; Loktionova, N. A.; Pegg, A. E.; Parker, R. J.; Pauly, G.; Widemann, B. C.; Balis, F. M.; Fox, E.
  3. Cancer Chemotherapy and Pharmacology. 2011, Jun; 67(6): 1291-1297.
  1. 6.   Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
  2. Kang, Z. G.; Chen, J. J.; Yu, Y. K.; Li, B.; Sun, S. Y.; Zhang, B. L.; Cao, L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3181-3192.
  1. 7.   BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
  2. Crea, F.; Serrat, M. A. D.; Hurt, E. M.; Thomas, S. B.; Danesi, R.; Farrar, W. L.
  3. International Journal of Cancer. 2011, Apr; 128(8): 1946-1954.
  1. 8.   Differential microRNA regulation of HLA-C expression and its association with HIV control
  2. Kulkarni, S.; Savan, R.; Qi, Y.; Gao, X. J.; Yuki, Y.; Bass, S. E.; Martin, M. P.; Hunt, P.; Deeks, S. G.; Telenti, A.; Pereyra, F.; Goldstein, D.; Wolinsky, S.; Walker, B.; Young, H. A.; Carrington, M.
  3. Nature. 2011, Apr; 472(7344): 495-U548.
  1. 9.   Similarity in Recombination Rate Estimates Highly Correlates with Genetic Differentiation in Humans
  2. Laayouni, H. L. H.; Montanucci, L.; Sikora, M.; Mele, M.; Dall'Olio, G. M.; Lorente-Galdos, B.; McGee, K. M.; Graffelman, J.; Awadalla, P.; Bosch, E.; Comas, D.; Navarro, A.; Calafell, F.; Casals, F.; Bertranpetit, J.
  3. Plos One. 2011, Mar; 6(3): 8.
  1. 10.   Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors
  2. Maddali, K.; Kumar, V.; March, C.; Pommier, Y.; Malhotra, S. V.
  3. Medchemcomm. 2011, Feb; 2(2): 143-150.
  1. 11.   The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy
  2. Xiang, X. R.; Phung, Y.; Feng, M. Q.; Nagashima, K.; Zhang, J. L.; Broaddus, V. C.; Hassan, R.; FitzGerald, D.; Ho, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 12.   STAT1 activation regulates proliferation and differentiation of renal progenitors
  2. Wang, H.; Yang, Y.; Sharma, N.; Tarasova, N. I.; Timofeeva, O. A.; Winkler-Pickett, R. T.; Tanigawa, S.; Perantoni, A. O.
  3. Cellular Signalling. 2010, Nov; 22(11): 1717-1726.
  1. 13.   Plant Natural Products in Anticancer Drug Discovery
  2. Grothaus, P. G.; Cragg, G. M.; Newman, D. J.
  3. Current Organic Chemistry. 2010, Oct; 14(16): 1781-1791.
  1. 14.   A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds
  2. Screpanti, E.; Santaguida, S.; Nguyen, T.; Silvestri, R.; Gussio, R.; Musacchio, A.; Hamel, E.; De Wulf, P.
  3. Plos One. 2010, Jul; 5(7): 13.
  1. 15.   The odyssey of marine pharmaceuticals: a current pipeline perspective
  2. Mayer, A. M. S.; Glaser, K. B.; Cuevas, C.; Jacobs, R. S.; Kem, W.; Little, R. D.; McIntosh, J. M.; Newman, D. J.; Potts, B. C.; Shuster, D. E.
  3. Trends in Pharmacological Sciences. 2010, Jun; 31(6): 255-265.
  1. 16.   Antitumor activity and COMPARE analysis of bis-indole derivatives
  2. Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Landi, L.; Prata, C.; Dalla Sega, F. V.; Caliceti, C.; Shoemaker, R. H.
  3. Bioorganic & Medicinal Chemistry. 2010, May; 18(9): 3004-3011.
  1. 17.   Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer
  2. Yan, X. D.; Yin, J.; Yao, H. Y.; Mao, N.; Yang, Y. L.; Pan, L. Y.
  3. Cancer Research. 2010, Feb; 70(4): 1616-1624.
  1. 18.   A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids
  2. Malhotra, S. V.; Kumar, V.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(2): 581-585.
  1. 19.   Peloruside B, A Potent Antitumor Macrolide from the New Zealand Marine Sponge Mycale hentscheli: Isolation, Structure, Total Synthesis, and Bioactivity
  2. Singh, A. J.; Xu, C. X.; Xu, X. M.; West, L. M.; Wilmes, A.; Chan, A.; Hamel, E.; Miller, J. H.; Northcote, P. T.; Ghosh, A. K.
  3. Journal of Organic Chemistry. 2010, Jan; 75(1): 2-10.
  1. 20.   Inheritance of susceptibility to induction of nephroblastomas in the Noble rat
  2. Diwan, B. A.; Timofeeva, O.; Rice, J. M.; Yang, Y. L.; Sharma, N.; Fortini, M. E.; Wang, H. H.; Perantoni, A. O.
  3. Differentiation. 2009, Apr; 77(4): 424-432.
  1. 21.   Intracellular Activation and Deactivation of Tasidotin, an Analog of Dolastatin 15: Correlation with Cytotoxicity
  2. Bai, R.; Edler, M. C.; Bonate, P. L.; Copeland, T. D.; Pettit, G. R.; Luduena, R. F.; Hamel, E.
  3. Molecular Pharmacology. 2009 75(1): 218-226.
  1. 22.   Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis
  2. Cao, X. F.; Plasencia, C.; Kanzaki, A.; Yang, A.; Burke, T. R.; Neamati, N.
  3. Current Cancer Drug Targets. 2009 9(2): 189-201.
  1. 23.   Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples
  2. Erickson, H. S.; Albert, P. S.; Gillespie, J. W.; Rodriguez-Canales, J.; Linehan, W. M.; Pinto, P. A.; Chuaqui, R. F.; Emmert-Buck, M. R.
  3. Nature Protocols. 2009 4(6): 902-922.
  1. 24.   Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids
  2. Kumar, V.; Malhotra, S. V.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(16): 4643-4646.
  1. 25.   Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation
  2. MacDonald, C. J.; Cheng, R.; Roberts, D. D.; Wink, D. A.; Yeh, G. C.
  3. Journal of Biological Chemistry. 2009 284(33): 22099-22107.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel